Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
35.58 USD +3.70% Intraday chart for Spyre Therapeutics, Inc. -7.80% +65.33%
Mar. 26 Stifel Adjusts Spyre Therapeutics' Price Target to $54 From $36, Maintains Buy Rating MT
Mar. 18 Spyre Therapeutics, Inc. announced that it expects to receive $180.005 million in funding CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. Revisions Spyre Therapeutics, Inc.